Clinical Trial Update: A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Tenofovir disoproxil fumarate (TDF) monotherapy to the combination of Emtricitabine plus TDF for chronic hepatitis B in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Emtriva (emtricitabine)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2013-08-08